New vaccine platform promotes rare protective B cells
MIT News • 2/5/2026
Summary
A new vaccine platform utilizes a virus-like particle constructed with a DNA scaffold. This approach has the potential to generate broadly neutralizing antibody responses against HIV or influenza.